Par, Alkermes Sue Breckenridge To Block Generic Megace
Par Pharmaceutical Inc. and Alkermes Pharma Ireland Ltd. brought patent infringement allegations in New Jersey federal court Thursday against Breckenridge Pharmaceutical Inc. over the company's plans to make a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article